Trial Details

COMPLETED
Basic Information
Clinical ID c1172
Identifier NCT03824561
Trial Title Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Vedolizumab
Participant Information
Sponsor Takeda
City Tokyo
Country/Region Japan
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2019-02-01
Primary Completion Date 2025-02-12
Completion Date 2025-02-12